Success Metrics

Clinical Success Rate
89.6%

Based on 370 completed trials

Completion Rate
90%(370/413)
Active Trials
26(5%)
Results Posted
38%(142 trials)
Terminated
43(8%)

Phase Distribution

Ph phase_1
93
18%
Ph early_phase_1
6
1%
Ph not_applicable
51
10%
Ph phase_2
104
20%
Ph phase_3
122
23%
Ph phase_4
140
26%

Phase Distribution

99

Early Stage

104

Mid Stage

262

Late Stage

Phase Distribution516 total trials
Early Phase 1First-in-human
6(1.2%)
Phase 1Safety & dosage
93(18.0%)
Phase 2Efficacy & side effects
104(20.2%)
Phase 3Large-scale testing
122(23.6%)
Phase 4Post-market surveillance
140(27.1%)
N/ANon-phased studies
51(9.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.4%

370 of 428 finished

Non-Completion Rate

13.6%

58 ended early

Currently Active

26

trials recruiting

Total Trials

529

all time

Status Distribution
Active(36)
Completed(370)
Terminated(58)
Other(65)

Detailed Status

Completed370
unknown64
Terminated43
Recruiting15
Withdrawn15
Active, not recruiting11

Development Timeline

Analytics

Development Status

Total Trials
529
Active
26
Success Rate
89.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.2%)
Phase 193 (18.0%)
Phase 2104 (20.2%)
Phase 3122 (23.6%)
Phase 4140 (27.1%)
N/A51 (9.9%)

Trials by Status

completed37070%
recruiting153%
enrolling_by_invitation10%
not_yet_recruiting92%
suspended10%
withdrawn153%
unknown6412%
active_not_recruiting112%
terminated438%

Recent Activity

Clinical Trials (529)

Showing 20 of 529 trialsScroll for more
NCT06686615

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Active Not Recruiting
NCT07474649Phase 3

A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Not Yet Recruiting
NCT05790499Not Applicable

LDL-c Level Variability and Trained Immunity

Completed
NCT07624604Not Applicable

Evaluation of the Therapeutic Efficacy of Auricular Pellets Combined With Atorvastatin 20mg in Patients With Dyslipidemia and Phlegm-Dampness Syndrome

Completed
NCT04915183Phase 2

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Recruiting
NCT07534592Phase 1

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

Active Not Recruiting
NCT07762105Phase 1

Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease

Not Yet Recruiting
NCT07042165Phase 4

Treatment of Bile Acid Diarrhoea With Atorvastatin

Active Not Recruiting
NCT07045142Phase 3

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

Recruiting
NCT07727681Phase 4

Perioperative Statins to Prevent AFib After Lung Surgery

Recruiting
NCT06372925Phase 4

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Active Not Recruiting
NCT05404139Phase 2

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

Recruiting
NCT05483010Phase 2

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Recruiting
NCT07717788Not Applicable

Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

Completed
NCT03929744Phase 1

A Study of LY3502970 in Healthy Participants

Completed
NCT05705804Not Applicable

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

Recruiting
NCT07680595Phase 1

Prospective Management of Plaque Instability With Statins and Extra Folic Acid

Recruiting
NCT07668076Phase 2

The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

Completed
NCT07530289Phase 1

A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)

Completed
NCT07630363Phase 1

PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
529